UKSPA Directory 2017 2017-18 - Page 199

UKSPA Directory 2017 England | Associate Member 199 Progress to date P ha se 1 The phase one Incubator and grow-on space has been designed to provide serviced research offices and laboratory suites, built to high standards in sustainable construction. The building has been designed to achieve the highest possible energy efficiency and sustainability ratings. The Science Incubator has also been specified for a gigabit internet gateway for future occupiers. The first phase of development at Porton Science Park has been funded by Wiltshire Council, the Local Growth Fund via the Swindon and Wiltshire Local Enterprise Partnership, and European Regional Development Funding via the European Structural and Investment Fund. Wiltshire Council is working closely with Public Health England (PHE) and Dstl as stakeholder partners on future growth of the Science Park. PHE is in transition with a campus programme that will see significant elements of its science base relocate to Harlow in Essex by 2024. PHE will retain a presence on the Porton campus in the form of its regional Food, Water and Environment laboratory and a Cancer Registry, currently located in West Dean. The biologic drug and vaccine manufacturing operations of PHE have been transferred to a company wholly owned by the Department of Health, Porton Biopharma Ltd (PBL); and this will continue to operate from the current PHE site for the foreseeable future. ■ Trans por t l i nks Excellent rail links from Salisbury Close to the A303 Access to the M3, M4 and M27 P ha se 2 Overall, 10ha of the Science Park are allocated for further phases of development. Loc a t io n The Science Park is located in the heart of south Wiltshire, close to the A303, the major arterial road from London to the South West. “The vision for PSP is to become a focus for market growth and innovation” Ne a r by Str a te g i c n e tw o r k Cathedral city of Salisbury Southampton, Swindon, Bristol Southampton and Bath Universities Defence Science Technology Lab. PHE Porton/Porton Biopharma Ltd QinetiQ